Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial-Reference-Cited by-同舟云学术

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial

Published:2014-08 Issue:9 Volume:15 Page:997-1006
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Coleman Robert,Cameron David,Dodwell David,Bell Richard,Wilson Caroline,Rathbone Emma,Keane Maccon,Gil Miguel,Burkinshaw Roger,Grieve Robert,Barrett-Lee Peter,Ritchie Diana,Liversedge Victoria,Hinsley Samantha,Marshall Helen

Publisher

Elsevier BV

Subject

Oncology

Reference23 articles.

1. Preparing the ‘soil’: the premetastatic niche;Kaplan;Cancer Res,2006

2. Cancer to bone: a fatal attraction;Weilbaecher;Nat Rev Cancer,2011

3. Mechanisms of bone metastasis;Roodman;N Engl J Med,2004

4. Effects of bone-targeted agents on cancer progression and mortality;Coleman;J Natl Cancer Inst,2012

5. Breast cancer adjuvant therapy with zoledronic acid;Coleman;N Engl J Med,2011

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Characterization of a Peptide-Bisphosphonate Nanoparticle for the Treatment of Breast Cancer;Molecular Pharmaceutics;2024-08-28

2. Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study;Journal of Clinical Oncology;2024-08-20

3. The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence;Frontiers in Oncology;2024-08-01

4. Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-07-09

5. The role of IL-1B in breast cancer bone metastasis;Journal of Bone Oncology;2024-06